Problems at Baltimore Plant Jeopardize Millions of J&J Vaccine Doses

Johnson & Johnson, the creator of the FDA-approved single-dose coronavirus vaccine, has identified a problem at a Baltimore plant helping to manufacture the vaccine.

The New York Times first reported Wednesday that workers at Baltimore’s Emergent BioSolutions accidentally mixed some of the ingredients, ruining as many as 15 million doses of the vaccine and delaying FDA authorization of the facility.

The company said in an emailed statement to CNN that the plant’s quality-control system identified “one batch” of drug substance which didn’t meet standards, noting the questionable batch was part of a test run and quality check.

“This batch was never advanced to the filing and finishing stages of our manufacturing process,” the company statement said, CNN reported.

Johnson & Johnson said Wednesday that the setback didn’t affect its goal of delivering 20 million coronavirus vaccine doses by March’s end, which it said it was still on pace to reach. The doses to fill that shipment were manufactured in the company’s Netherlands plant, CNN reported.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Adblock Detected

Please consider supporting us by disabling your ad blocker